Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-02

FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for TOBI PODHALER (tobramycin) from Viatris Specialty LLC. The action relates to the continued use of the inhaled antibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBI Podhaler (tobramycin inhalation powder)

Snippet

SUPPL AP for TOBI PODHALER (TOBRAMYCIN)